The development of effective treatments for cardiovascular diseases and related conditions like benign prostatic hyperplasia (BPH) often hinges on the availability of specialized chemical compounds. 4-Amino-2-chloro-6,7-dimethoxyquinazoline, a chemical entity identified by its CAS number 23680-84-4, plays a fundamental role in this therapeutic area as a key intermediate in the synthesis of widely prescribed medications.

NINGBO INNO PHARMCHEM CO.,LTD. is a dedicated supplier of high-quality chemical intermediates, understanding that compounds like 4-Amino-2-chloro-6,7-dimethoxyquinazoline form the chemical backbone of many essential drugs. Specifically, this intermediate is crucial for the synthesis of Terazosin hydrochloride and Doxazosin. Terazosin is recognized for its efficacy in treating the symptoms of BPH by acting as an alpha1-antagonist. Doxazosin, also an alpha1 blocker, is vital in managing hypertension and BPH.

The production of these pharmaceuticals necessitates intermediates that are not only chemically precise but also possess a high degree of purity to ensure the safety and efficacy of the final drug product. NINGBO INNO PHARMCHEM CO.,LTD. supplies 4-Amino-2-chloro-6,7-dimethoxyquinazoline with a purity of ≥99.0%, meeting rigorous quality benchmarks. This commitment to quality is essential for any chemical synthesis project aiming for pharmaceutical-grade output. Whether for established Terazosin hydrochloride synthesis or for research into new cardiovascular therapies, the reliability of this pharmaceutical intermediate is paramount.

For researchers and manufacturers in the pharmaceutical sector, understanding the properties and applications of critical intermediates such as 4-Amino-2-chloro-6,7-dimethoxyquinazoline (CAS 23680-84-4) is vital. NINGBO INNO PHARMCHEM CO.,LTD. provides the assurance of quality for these essential building blocks, supporting advancements in cardiovascular health treatment.